 | • レポートコード：D005-04652 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、クローン病治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。クローン病治療薬の種類別市場規模（アミノサリチル酸（5-ASA）、コルチコステロイド、免疫調節剤、抗生物質）、用途別市場規模（寛解緩和（症状欠如）、寛解維持（再発予防）、小児クローン病）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie、Amgen、Janssen Biotech、UCB、Takeda Pharmaceuticals、Tillotts Pharma ・地域別グローバル市場分析 2015年-2020年 ・クローン病治療薬の北米市場（アメリカ、カナダ、メキシコ） ・クローン病治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・クローン病治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・クローン病治療薬の南米市場（ブラジル、アルゼンチン） ・クローン病治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アミノサリチル酸（5-ASA）、コルチコステロイド、免疫調節剤、抗生物質 ・用途別分析：寛解緩和（症状欠如）、寛解維持（再発予防）、小児クローン病 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Crohn’s Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Crohn’s Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Crohn’s Disease Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Crohn’s Disease Drug market has been segmented into
Aminosalicylates (5-ASA)
Corticosteroids
Immunomodulators
Antibiotics
By Application, Crohn’s Disease Drug has been segmented into:
Achieving Remission (The Absence Of Symptoms)
Maintaining Remission (Prevention Of Flare-Ups)
Pediatric Crohn’S Disease
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Crohn’s Disease Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Crohn’s Disease Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Crohn’s Disease Drug market.
The report offers in-depth assessment of the growth and other aspects of the Crohn’s Disease Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Crohn’s Disease Drug Market Share Analysis
Crohn’s Disease Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Crohn’s Disease Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Crohn’s Disease Drug sales, revenue and market share for each player covered in this report.
The major players covered in Crohn’s Disease Drug are:
AbbVie
Amgen
Janssen Biotech
UCB
Takeda Pharmaceuticals
Tillotts Pharma
Among other players domestic and global, Crohn’s Disease Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Crohn’s Disease Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Crohn’s Disease Drug, with price, sales, revenue and global market share of Crohn’s Disease Drug in 2018 and 2019.
Chapter 3, the Crohn’s Disease Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Crohn’s Disease Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Crohn’s Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Crohn’s Disease Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Crohn’s Disease Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Crohn’s Disease Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Aminosalicylates (5-ASA)
1.2.3 Corticosteroids
1.2.4 Immunomodulators
1.2.5 Antibiotics
1.3 Market Analysis by Application
1.3.1 Overview: Global Crohn’s Disease Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Achieving Remission (The Absence Of Symptoms)
1.3.3 Maintaining Remission (Prevention Of Flare-Ups)
1.3.4 Pediatric Crohn’S Disease
1.4 Overview of Global Crohn’s Disease Drug Market
1.4.1 Global Crohn’s Disease Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie Crohn’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Amgen SWOT Analysis
2.2.4 Amgen Product and Services
2.2.5 Amgen Crohn’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Janssen Biotech
2.3.1 Janssen Biotech Details
2.3.2 Janssen Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Janssen Biotech SWOT Analysis
2.3.4 Janssen Biotech Product and Services
2.3.5 Janssen Biotech Crohn’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 UCB
2.4.1 UCB Details
2.4.2 UCB Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 UCB SWOT Analysis
2.4.4 UCB Product and Services
2.4.5 UCB Crohn’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Takeda Pharmaceuticals
2.5.1 Takeda Pharmaceuticals Details
2.5.2 Takeda Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Takeda Pharmaceuticals SWOT Analysis
2.5.4 Takeda Pharmaceuticals Product and Services
2.5.5 Takeda Pharmaceuticals Crohn’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Tillotts Pharma
2.6.1 Tillotts Pharma Details
2.6.2 Tillotts Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Tillotts Pharma SWOT Analysis
2.6.4 Tillotts Pharma Product and Services
2.6.5 Tillotts Pharma Crohn’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Crohn’s Disease Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Crohn’s Disease Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Crohn’s Disease Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Crohn’s Disease Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Crohn’s Disease Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Crohn’s Disease Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Crohn’s Disease Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
4.3 Europe Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
4.5 South America Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Crohn’s Disease Drug Sales, Revenue and Market Share by Country
5.1.1 North America Crohn’s Disease Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Crohn’s Disease Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
5.3 Canada Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Crohn’s Disease Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Crohn’s Disease Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Crohn’s Disease Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
6.3 UK Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
6.4 France Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
6.5 Russia Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
6.6 Italy Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Crohn’s Disease Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Crohn’s Disease Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Crohn’s Disease Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
7.3 Japan Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
7.4 Korea Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
7.5 India Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
7.7 Australia Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Crohn’s Disease Drug Sales, Revenue and Market Share by Country
8.1.1 South America Crohn’s Disease Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Crohn’s Disease Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Crohn’s Disease Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Crohn’s Disease Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Crohn’s Disease Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Crohn’s Disease Drug Sales and Market Share by Type (2015-2020)
10.2 Global Crohn’s Disease Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Crohn’s Disease Drug Price by Type (2015-2020)
11 Global Crohn’s Disease Drug Market Segment by Application
11.1 Global Crohn’s Disease Drug Sales Market Share by Application (2015-2020)
11.2 Global Crohn’s Disease Drug Revenue Market Share by Application (2015-2020)
11.3 Global Crohn’s Disease Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Crohn’s Disease Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Crohn’s Disease Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Crohn’s Disease Drug Market Forecast (2021-2025)
12.2.2 Europe Crohn’s Disease Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Crohn’s Disease Drug Market Forecast (2021-2025)
12.2.4 South America Crohn’s Disease Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Crohn’s Disease Drug Market Forecast (2021-2025)
12.3 Crohn’s Disease Drug Market Forecast by Type (2021-2025)
12.3.1 Global Crohn’s Disease Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Crohn’s Disease Drug Market Share Forecast by Type (2021-2025)
12.4 Crohn’s Disease Drug Market Forecast by Application (2021-2025)
12.4.1 Global Crohn’s Disease Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Crohn’s Disease Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Crohn’s Disease Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Crohn’s Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Crohn’s Disease Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AbbVie Basic Information, Manufacturing Base and Competitors
Table 8. AbbVie Crohn’s Disease Drug Major Business
Table 9. AbbVie Crohn’s Disease Drug Total Revenue (USD Million) (2017-2018)
Table 10. AbbVie SWOT Analysis
Table 11. AbbVie Crohn’s Disease Drug Product and Services
Table 12. AbbVie Crohn’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Amgen Basic Information, Manufacturing Base and Competitors
Table 14. Amgen Crohn’s Disease Drug Major Business
Table 15. Amgen Crohn’s Disease Drug Total Revenue (USD Million) (2017-2018)
Table 16. Amgen SWOT Analysis
Table 17. Amgen Crohn’s Disease Drug Product and Services
Table 18. Amgen Crohn’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table 20. Janssen Biotech Crohn’s Disease Drug Major Business
Table 21. Janssen Biotech Crohn’s Disease Drug Total Revenue (USD Million) (2017-2018)
Table 22. Janssen Biotech SWOT Analysis
Table 23. Janssen Biotech Crohn’s Disease Drug Product and Services
Table 24. Janssen Biotech Crohn’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. UCB Basic Information, Manufacturing Base and Competitors
Table 26. UCB Crohn’s Disease Drug Major Business
Table 27. UCB Crohn’s Disease Drug Total Revenue (USD Million) (2017-2018)
Table 28. UCB SWOT Analysis
Table 29. UCB Crohn’s Disease Drug Product and Services
Table 30. UCB Crohn’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Takeda Pharmaceuticals Crohn’s Disease Drug Major Business
Table 33. Takeda Pharmaceuticals Crohn’s Disease Drug Total Revenue (USD Million) (2017-2018)
Table 34. Takeda Pharmaceuticals SWOT Analysis
Table 35. Takeda Pharmaceuticals Crohn’s Disease Drug Product and Services
Table 36. Takeda Pharmaceuticals Crohn’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Tillotts Pharma Basic Information, Manufacturing Base and Competitors
Table 38. Tillotts Pharma Crohn’s Disease Drug Major Business
Table 39. Tillotts Pharma Crohn’s Disease Drug Total Revenue (USD Million) (2017-2018)
Table 40. Tillotts Pharma SWOT Analysis
Table 41. Tillotts Pharma Crohn’s Disease Drug Product and Services
Table 42. Tillotts Pharma Crohn’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Global Crohn’s Disease Drug Sales by Manufacturer (2018-2019) (K MT)
Table 44. Global Crohn’s Disease Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 45. Global Crohn’s Disease Drug Sales by Regions (2015-2020) (K MT)
Table 46. Global Crohn’s Disease Drug Sales Market Share by Regions (2015-2020)
Table 47. Global Crohn’s Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 48. North America Crohn’s Disease Drug Sales by Countries (2015-2020) (K MT)
Table 49. North America Crohn’s Disease Drug Sales Market Share by Countries (2015-2020)
Table 50. North America Crohn’s Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 51. North America Crohn’s Disease Drug Revenue Market Share by Countries (2015-2020)
Table 52. Europe Crohn’s Disease Drug Sales by Countries (2015-2020) (K MT)
Table 53. Europe Crohn’s Disease Drug Sales Market Share by Countries (2015-2020)
Table 54. Europe Crohn’s Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 55. Asia-Pacific Crohn’s Disease Drug Sales by Regions (2015-2020) (K MT)
Table 56. Asia-Pacific Crohn’s Disease Drug Sales Market Share by Regions (2015-2020)
Table 57. Asia-Pacific Crohn’s Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 58. South America Crohn’s Disease Drug Sales by Countries (2015-2020) (K MT)
Table 59. South America Crohn’s Disease Drug Sales Market Share by Countries (2015-2020)
Table 60. South America Crohn’s Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 61. South America Crohn’s Disease Drug Revenue Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Crohn’s Disease Drug Sales by Countries (2015-2020) (K MT)
Table 63. Middle East & Africa Crohn’s Disease Drug Sales Market Share by Countries (2015-2020)
Table 64. Middle East & Africa Crohn’s Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 65. Middle East & Africa Crohn’s Disease Drug Revenue Market Share by Countries (2015-2020)
Table 66. Global Crohn’s Disease Drug Sales by Type (2015-2020) (K MT)
Table 67. Global Crohn’s Disease Drug Sales Share by Type (2015-2020)
Table 68. Global Crohn’s Disease Drug Revenue by Type (2015-2020) (USD Million)
Table 69. Global Crohn’s Disease Drug Revenue Share by Type (2015-2020)
Table 70. Global Crohn’s Disease Drug Sales by Application (2015-2020) (K MT)
Table 71. Global Crohn’s Disease Drug Sales Share by Application (2015-2020)
Table 72. Global Crohn’s Disease Drug Sales Forecast by Regions (2021-2025) (K MT)
Table 73. Global Crohn’s Disease Drug Market Share Forecast by Regions (2021-2025)
Table 74. Global Crohn’s Disease Drug Sales Forecast by Type (2021-2025) (K MT)
Table 75. Global Crohn’s Disease Drug Market Share Forecast by Type (2021-2025)
Table 76. Global Crohn’s Disease Drug Sales Forecast by Application (2021-2025)
Table 77. Global Crohn’s Disease Drug Market Share Forecast by Application (2021-2025)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Crohn’s Disease Drug Picture
Figure 2. Global Sales Market Share of Crohn’s Disease Drug by Type in 2019
Figure 3. Aminosalicylates (5-ASA) Picture
Figure 4. Corticosteroids Picture
Figure 5. Immunomodulators Picture
Figure 6. Antibiotics Picture
Figure 7. Crohn’s Disease Drug Sales Market Share by Application in 2018
Figure 8. Achieving Remission (The Absence Of Symptoms) Picture
Figure 9. Maintaining Remission (Prevention Of Flare-Ups) Picture
Figure 10. Pediatric Crohn'S Disease Picture
Figure 11. Global Crohn’s Disease Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Crohn’s Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Crohn’s Disease Drug Sales Market Share by Manufacturer in 2019
Figure 32. Global Crohn’s Disease Drug Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Crohn’s Disease Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Crohn’s Disease Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 37. Global Crohn’s Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Crohn’s Disease Drug Revenue Market Share by Regions (2015-2020)
Figure 39. Global Crohn’s Disease Drug Revenue Market Share by Regions in 2018
Figure 40. North America Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
Figure 41. Europe Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
Figure 43. South America Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Crohn’s Disease Drug Sales and Growth Rate (2015-2020)
Figure 45. North America Crohn’s Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Crohn’s Disease Drug Sales Market Share by Countries (2015-2020)
Figure 47. North America Crohn’s Disease Drug Sales Market Share by Countries in 2018
Figure 48. North America Crohn’s Disease Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Crohn’s Disease Drug Revenue Market Share by Countries in 2018
Figure 50. United States Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Canada Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Mexico Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Europe Crohn’s Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Crohn’s Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Crohn’s Disease Drug Revenue Market Share by Countries in 2019
Figure 56. Germany Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 57. UK Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 58. France Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Russia Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Italy Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Asia-Pacific Crohn’s Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Crohn’s Disease Drug Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Crohn’s Disease Drug Revenue Market Share by Regions 2019
Figure 64. China Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Japan Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Korea Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 67. India Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Southeast Asia Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 69. South America Crohn’s Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Crohn’s Disease Drug Sales Market Share by Countries in 2019
Figure 71. South America Crohn’s Disease Drug Revenue Market Share by Countries in 2019
Figure 72. Brazil Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Argentina Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Middle East and Africa Crohn’s Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Crohn’s Disease Drug Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Crohn’s Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Crohn’s Disease Drug Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Egypt Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Turkey Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 81. South Africa Crohn’s Disease Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Global Crohn’s Disease Drug Sales and Growth Rate (2021-2025) (K MT)
Figure 83. Global Crohn’s Disease Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Crohn’s Disease Drug Market Forecast (2021-2025) (K MT)
Figure 85. Europe Sales Crohn’s Disease Drug Market Forecast (2021-2025) (K MT)
Figure 86. Asia-Pacific Sales Crohn’s Disease Drug Market Forecast (2021-2025) (K MT)
Figure 87. South America Sales Crohn’s Disease Drug Market Forecast (2021-2025) (K MT)
Figure 88. Middle East & Africa Sales Crohn’s Disease Drug Market Forecast (2021-2025) (K MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
病気管理＆予防ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Disease Control and Prevention Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 55270 million by 2025, from USD 42850 million in 2019. The…- 併用療法薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Combination Therapy Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Combination Therapy …
- シャーガス病治療の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chagas Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 253.5 million by 2025, from USD 223.8 million in 2019. The Chagas Diseas…
- 植物薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Botanical Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Botanical Drug market report p…
- アレルギー鼻炎薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Allergy Rhinitis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Allergy Rhinitis Drug m…